Monopolist Aspen got the opportunity to raise the price of essential NHS medicine by 1,800 per cent
Key points from article :
Collusion by three pharmaceutical firms has resulted in price rises for a life-saving drug purchased by the NHS.
Thousands of patients rely on fludrocortisone to treat what is known as Addison’s disease.
Aspen will pay the NHS £8m to resolve another competition issue related to the supply of fludrocortisone.
Click on resource name for more details.
Company focused on a broad range of post-patent, branded medicines, and domestic brands spanning many therapeutic areas
written by Olesya Dmitracova
